Publicaciones en las que colabora con José Mir (11)

2014

  1. Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction

    Journal of Hepatology, Vol. 61, Núm. 3, pp. 564-574

  2. Neonatal livers: A source for the isolation of good-performing hepatocytes for cell transplantation

    Cell Transplantation, Vol. 23, Núm. 10, pp. 1229-1242

2010

  1. Functional characterization of hepatocytes for cell transplantation: Customized cell preparation for each receptor

    Cell Transplantation, Vol. 19, Núm. 1, pp. 21-28

2008

  1. Desarrollo, análisis y optimización de modelos celulares hepáticos para estudios de fármaco-toxicología y terapia celular

    Anales de la Real Academia Nacional de Farmacia, Vol. 74, Núm. 2, pp. 283-306

  2. Functional assessment of the quality of human hepatocyte preparations for cell transplantation

    Cell Transplantation, Vol. 17, Núm. 10-11, pp. 1211-1219

2007

  1. Effects of steatosis on drug-metabolizing capability of primary human hepatocytes

    Toxicology in Vitro, Vol. 21, Núm. 2, pp. 271-276

2006

  1. Potential impact of steatosis on cytochrome P450 enzymes of human hepatocytes isolated from fatty liver grafts

    Drug Metabolism and Disposition, Vol. 34, Núm. 9, pp. 1556-1562

2005

  1. Influence of preservation solution on the isolation and culture of human hepatocytes from liver grafts

    Cell Transplantation, Vol. 14, Núm. 10, pp. 837-843

  2. Liver grafts preserved in Celsior solution as source of hepatocytes for drug metabolism studies: Comparison with surgical liver biopsies

    Drug Metabolism and Disposition, Vol. 33, Núm. 1, pp. 108-114

2004

  1. The immunosuppressant drug FK506 prevents Fas-induced apoptosis in human hepatocytes

    Biochemical Pharmacology, Vol. 68, Núm. 12, pp. 2427-2433

2003

  1. Functionality of cultured human hepatocytes from elective samples, cadaveric grafts and hepatectomies

    Toxicology in Vitro